Olema Pharmaceuticals, Inc. (OLMA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-06-23

Olema Pharmaceuticals, Inc. (OLMA) has filed 12 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. 6 Form 8-K material event filings were reported by OLMA in the last 90 days. InsiderAlpha tracks every OLMA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Olema Pharmaceuticals, Inc. (OLMA)

SEC CIK0001750284

90-Day SEC Filing Activity

Form 4 filings (90d)12
Form 8-K filings (90d)6
Latest Form 4 filing2026-06-23

Recent OLMA Insider Transactions (Form 4)

DateInsiderRoleTransactionSharesPriceValueFiling
Mitchell ShawnteCHIEF LEGAL OFFICERS — Open-market sale233$24.69$6KSEC
Mitchell ShawnteCHIEF LEGAL OFFICERM — Option exercise25.0K$4.37$109KSEC
Mitchell ShawnteCHIEF LEGAL OFFICERS — Open-market sale24.8K$24.25$601KSEC
Mitchell ShawnteCHIEF LEGAL OFFICERM — Option exercise15.0K$4.37$66KSEC
Mitchell ShawnteCHIEF LEGAL OFFICERS — Open-market sale15.0K$23.01$345KSEC
Austin Sasha LuVP of Finance and ControllerA — Grant or award11.7K$0.00—SEC
Harmon CyrusInsiderS — Open-market sale10.0K$26.88$269KSEC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.S — Open-market sale100.0K$28.73$2.87MSEC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFS — Open-market sale35.0K$28.99$1.01MSEC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFM — Option exercise50.0K$4.87$244KSEC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFS — Open-market sale15.0K$28.60$429KSEC
Harmon CyrusInsiderS — Open-market sale3.5K$29.12$102KSEC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFS — Open-market sale49.8K$27.60$1.37MSEC
Myles David C.CH. DISCOV. & NON-CLIN DEV OFFS — Open-market sale200$28.49$6KSEC
Kovacs Shane William CharlesCH. OPERATING & FINANCIAL OFF.S — Open-market sale3.8K$28.01$107KSEC

All transactions sourced from SEC EDGAR Form 4 filings for Olema Pharmaceuticals, Inc. (OLMA). Updated in real time as new filings are submitted to the SEC.

Most-Active OLMA Insiders — Last 90 Days

InsiderForm 4 filingsTotal transaction value
Raman Prakash3—
CLARK IAN T1—
BUTITTA CYNTHIA M1—
Garland J. Scott1—
Graham G. Walmsley1—

Recent OLMA Form 8-K Material Events

Recent Insider Filings

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in OLMA insider filings:

POpen-market purchase by the insider
SOpen-market sale by the insider
AGrant, award, or other acquisition from the issuer
MExercise or conversion of derivative security (e.g. options)
FPayment of exercise price or tax liability via share withholding
GBona-fide gift of securities
DDisposition to the issuer (e.g. share buyback participation)
JOther acquisition or disposition
XExercise of in-the-money or at-the-money derivative security
CConversion of derivative security
VTransaction voluntarily reported earlier than required

OLMA Insider Trading — FAQ

What is the latest insider trade for OLMA?
Olema Pharmaceuticals, Inc. (OLMA) had 12 insider filings in the last 90 days, with the most recent on 2026-06-23. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying OLMA stock?
0 insider purchases of OLMA were filed in the last 90 days.
How many insiders are selling OLMA stock?
0 insider sales of OLMA were filed in the last 90 days.
Where can I see OLMA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
InsiderAlpha aggregates every OLMA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live OLMA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.